Prague Med. Rep. 2015, 116, 112-121

https://doi.org/10.14712/23362936.2015.50

Changes in the Pattern of Primary Hyperparathyroidism in Czech Republic

Petr Broulík1, Svatopluk Adámek2, Petr Libánský2, Jozef Kubinyi3

13rd Department of Medicine – Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
23rd Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
3Institute of Nuclear Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic

Received February 16, 2015
Accepted June 1, 2015

Crossref Cited-by Linking

  • Pal Rimesh, Banerjee Mainak, Prasad Trupti N., Kumar Ashok, Bhadada Tushar, Vyas Abhinav, Mukhopadhyay Satinath, Bhadada Sanjay Kumar: Risk of Gallstone Disease in Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. Endocrine Practice 2024, 30, 225. <https://doi.org/10.1016/j.eprac.2023.12.002>
  • Baranova I. A., Baranov A. V.: Pathology of the Gastrointestinal Tract in Patients with Primary Hyperparathyroidism. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2023, 32, 24. <https://doi.org/10.22416/1382-4376-2022-32-5-24-30>
  • Chen Rong, Song An, Wang Ou, Jiang Yan, Li Mei, Xia Weibo, Lin Xue, Xing Xiaoping: The preliminary study on cardiac structure and function in Chinese patients with primary hyperparathyroidism. Front. Endocrinol. 2023, 14. <https://doi.org/10.3389/fendo.2023.1083521>
  • Minisola Salvatore, Arnold Andrew, Belaya Zhanna, Brandi Maria Luisa, Clarke Bart L., Hannan Fadil M., Hofbauer Lorenz C., Insogna Karl L., Lacroix André, Liberman Uri, Palermo Andrea, Pepe Jessica, Rizzoli René, Wermers Robert, Thakker Rajesh V.: Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism. Journal of Bone and Mineral Research 2020, 37, 2315. <https://doi.org/10.1002/jbmr.4665>
  • Bilezikian John P., Khan Aliya A., Silverberg Shonni J., Fuleihan Ghada El-Hajj, Marcocci Claudio, Minisola Salvatore, Perrier Nancy, Sitges-Serra Antonio, Thakker Rajesh V., Guyatt Gordon, Mannstadt Michael, Potts John T., Clarke Bart L., Brandi Maria Luisa: Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research 2020, 37, 2293. <https://doi.org/10.1002/jbmr.4677>
  • Thorsteinsson Anne-Luise, Hansen Louise, Vestergaard Peter, Eiken Pia: Long-term benefits and risks of parathyroid hormone treatment in compliant osteoporotic patients. A Danish national register based cohort study. Arch Osteoporos 2018, 13. <https://doi.org/10.1007/s11657-018-0444-6>
  • Rao Sudhaker D.: Epidemiology of parathyroid disorders. Best Practice & Research Clinical Endocrinology & Metabolism 2018, 32, 773. <https://doi.org/10.1016/j.beem.2018.12.003>
  • Šiprová Helena, Souček Miroslav, Šipr Květoslav: Current problems of primary hyperparathyroidism in clinical practice. Interní Med. 2016, 18, 134. <https://doi.org/10.36290/int.2016.031>
  • Šiprová Helena, Fryšák Zdeněk, Souček Miroslav: Primary Hyperparathyroidism, With A Focus On Management Of The Normocalcemic Form: To Treat Or Not To Treat?. Endocrine Practice 2016, 22, 294. <https://doi.org/10.4158/EP15704.OR>
Crossref Cited-by Linking logo